• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medication during pregnancy and nursing is a difficult decision for women suffering from the condition. There aren't many studies regarding how exposure over time may affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus don't develop neurological developmental conditions like hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Pregnant women who use ADHD medications must weigh the benefits of using them against the risks to the fetus. The doctors don't have the information to give clear advice however they can provide information on the risks and benefits to assist pregnant women to make informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication in early pregnancy were not at greater risk of fetal malformations, or structural birth defects. Researchers used a vast, population-based case-control study to evaluate the incidence of major structural birth defects in infants born to mothers who took stimulants during early pregnancy, and those who did not. Clinical geneticists, pediatric cardiologists and other experts examined the cases to confirm that the classification was accurate and to minimize any bias.

However, the study was not without its flaws. Most important, they were unable to separate the effects of the medication from the disorder at hand. That limitation makes it difficult to determine whether the small associations observed in the groups that were exposed are due to the use of medication or comorbidities that cause confusion. Additionally the researchers did not examine the long-term effects types of adhd medication offspring on their parents.

The study showed that infants whose mother had taken ADHD medication during pregnancy were at a slightly greater risk of being admitted to the neonatal care unit (NICU), compared to those whose mothers didn't take any medication during pregnancy, or had discontinued taking their medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who took stimulant adhd treatment medication medications during pregnancy also had a higher risk of having to have a caesarean section or one whose baby scored low on the Apgar scale (less than 7). These risks did not appear to be affected by the kind of medication used during pregnancy.

Researchers suggest that the minor risks associated with the use ADHD medications in early pregnancies can be offset by greater benefits for baby and mother of continued treatment for the woman’s disorder. Physicians should discuss the issue with their patients and, where they are able, assist them in developing strategies to improve their coping abilities which can reduce the negative impact of her condition on her daily functioning and relationships.

Medication Interactions

More and more doctors are faced with the decision of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are usually made without clear and reliable evidence. Instead, physicians must take into account their own experience in conjunction with the experiences of other doctors, and the research on the topic.

Particularly, the issue of potential risks to the baby can be a challenge. The research that has been conducted on this topic is based on observation rather than controlled studies, and a lot of the results are in conflict. most popular adhd medication studies restrict their analysis to live-births, which could underestimate the teratogenic impact which can cause terminations or abortions of pregnancy. The study presented in the journal club addresses these shortcomings by analyzing both data on live and deceased births.

The conclusion The conclusion: While certain studies have demonstrated an association between ADHD medications and the risk of certain birth defects, other studies have found no such relationship and the majority of studies have a neutral or slight negative effect. Therefore an accurate risk-benefit analysis is required in every instance.

It can be challenging, if not impossible, for women with ADHD to stop taking their medication. In a recent article in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of loneliness, and family conflict for patients with ADHD. Furthermore, a loss of medication can affect the ability to do job-related tasks and drive safely which are essential aspects of daily life for a lot of people with ADHD.

She suggests women who are unsure about whether or not to stop taking medication because of their pregnancy should consider the possibility of educating friends, family members, and coworkers on the condition, its effects on daily functioning, and on the advantages of staying on the current treatment plan. Educating them can also aid in ensuring that the woman feels supported when she is struggling with her decision. It is important to note that some medications are able to pass through the placenta therefore, if a patient decides to discontinue her ADHD medication during pregnancy and breastfeeding, she must be aware that the effects of the medication could be transferred to the child.

Birth Defects Risk

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases there are concerns about the effects that the drugs might have on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this topic. With two massive data sets researchers were able examine more than 4.3 million pregnancies to determine whether the use of stimulant medications increased the risk of birth defects. Researchers found that while the risk overall is low, the first trimester ADHD medication use was associated with slightly higher risk of certain heart defects, like ventriculoseptal defect.

The researchers of the study found no connection between early use of medication and other congenital abnormalities, such as facial clefting or club foot. The results are in agreement with previous studies that have shown the existence of a slight, but significant increase in cardiac malformations for women who started taking ADHD medication before pregnancy. The risk increased in the latter stages of pregnancy when many women stopped taking their medication.

Women who took adhd medication brands uk medications in the first trimester of their pregnancy were also more likely to undergo caesarean sections, a low Apgar score following delivery, and a baby who needed breathing assistance during birth. The researchers of the study were not able to eliminate selection bias because they limited the study to women with no other medical conditions that could have contributed to the findings.

The researchers hope their study will aid in the clinical decisions of doctors who treat pregnant women. The researchers suggest that, while discussing risks and benefits are important, the choice regarding whether or not to stop medication should be made based on the severity of each woman's ADHD symptoms and the needs of the woman.

The authors caution that, although stopping the medication is a possibility to think about, it isn't advised because of the high incidence of depression and mental health issues among women who are pregnant or recently gave birth. Furthermore, research suggests that women who choose to stop taking their medications are more likely to experience difficulties adapting to life without them after the baby's arrival.

Nursing

The responsibilities of being a new mom can be overwhelming. Women who suffer from ADHD who have to manage their symptoms while attending physician appointments and making preparations for the arrival of their child and adjusting to new household routines may face a lot of challenges. Many women decide to continue taking their ADHD medication during pregnancy.

The majority of stimulant drugs are absorbed through breast milk in small amounts, therefore the risk to the infant who is breastfeeding is low. However, the amount of exposure to medication by the infant can differ based on the dosage, frequency it is taken and the time of the day it is administered. Additionally, different medications enter the baby's system differently through the gastrointestinal tract as well as breast milk, and the effect of this on a newborn infant is not well understood.

Due to the absence of evidence, some doctors may be inclined to discontinue stimulant medication during the pregnancy of a woman. This is a complicated decision for the patient, who must balance the benefits of continuing her medication against the possible dangers to the foetus. In the meantime, until more information is available, doctors may ask pregnant patients if they have an history of ADHD or if they are planning to take medication in the perinatal phase.

A growing number of studies have revealed that most effective adhd medication women can safely continue taking their ADHD medication during pregnancy and breastfeeding. In response, most popular adhd medication a rising number of patients are choosing to continue their medication. They have found, in consultation with their doctor that the benefits of continuing their current medication outweigh potential risks.

Women who suffer from ADHD who plan to breastfeed should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss their medication with their doctor and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation should also be provided to help women with ADHD recognize their symptoms and underlying disorder, learn about available treatment options and strengthen existing strategies for coping. This should be a multidisciplinary process including obstetricians, GPs, and psychiatrists. Pregnancy counselling should include the discussion of a treatment plan for both the mother and child, and monitoring for signs of deterioration and the need for adjustments to the medication regimen.